As the oncogenic effects are closely related to pathogenesis, ATAD2 has emerged as a diagnostic and prognostic marker in numerous malignant tumors, and has attracted attention as a drug target for the inhibition of cancer progression. The gene discussed is ATAD2; the disease is cancer.